financetom
Business
financetom
/
Business
/
Hagerty Insider Sold Shares Worth $660,888, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hagerty Insider Sold Shares Worth $660,888, According to a Recent SEC Filing
Mar 11, 2026 12:37 AM

05:35 PM EST, 01/13/2026 (MT Newswires) -- Kenneth Ahn, President, Hagerty Marketplace, on January 09, 2026, sold 51,350 shares in Hagerty (HGTY) for $660,888. Following the Form 4 filing with the SEC, Ahn has control over a total of 113,593 Class A common shares of the company, with 113,593 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1840776/000162828026001989/xslF345X05/wk-form4_1768343230.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Microchip Technology Develops CEC1736 TrustFLEX Devices
Microchip Technology Develops CEC1736 TrustFLEX Devices
Mar 26, 2024
10:56 AM EDT, 03/26/2024 (MT Newswires) -- Microchip Technology ( MCHP ) said Tuesday it has developed new CEC1736 TrustFLEX devices that can support security features required to enable hardware root of trust across various markets. The devices are specifically designed to meet National Institute of Standards and Technology 800-193 platform resiliency guidelines, as well as Open Compute Project requirements,...
Beam Therapeutics Says BEAM-302 Drug Candidate Gets UK Clearance for Alpha-1 Antitrypsin Deficiency
Beam Therapeutics Says BEAM-302 Drug Candidate Gets UK Clearance for Alpha-1 Antitrypsin Deficiency
Mar 26, 2024
10:54 AM EDT, 03/26/2024 (MT Newswires) -- Beam Therapeutics ( BEAM ) said Tuesday that the UK's Medicines and Healthcare Products Regulatory Agency has cleared its clinical trial authorization application for BEAM-302, which is intended for the treatment of alpha-1 antitrypsin deficiency, an inherited genetic disorder. The company said it intends to roll out a phase 1/2 trial of BEAM-302...
Parsons Gets $28 Million Contract to Back US Air Force Research, Development Program
Parsons Gets $28 Million Contract to Back US Air Force Research, Development Program
Mar 26, 2024
10:55 AM EDT, 03/26/2024 (MT Newswires) -- Parsons (PSN) said Tuesday it was awarded a $28 million cost-plus-fixed-fee contract to support a research and development program of the US Air Force Research Laboratory. The company said it will provide intelligence, surveillance and reconnaissance command and control and space software baselines for the project. The contract includes one three-year performance period....
OneSpaWorld Holdings Raises $52.1 Million From Warrants Conversion
OneSpaWorld Holdings Raises $52.1 Million From Warrants Conversion
Mar 26, 2024
10:57 AM EDT, 03/26/2024 (MT Newswires) -- OneSpaWorld Holdings ( OSW ) said Tuesday that it raised $52.1 million in cash proceeds from the conversion of all its remaining public warrants. The company said most of the warrants were converted for cash and it now has about 106 million diluted shares following the conversion. The warrants' conversion, along with Steiner...
Copyright 2023-2026 - www.financetom.com All Rights Reserved